Holdings (Monthly)
Guide ↗
BlackRock Health Sciences Opportunities Portfolio
· BlackRock Funds| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY & COMPANY | LLY | Feb 2026 | 656,650 | -47,692 | $725.6M | -2.1% | 12.29% | EC |
| 2 | JOHNSON & JOHNSON | JNJ | Feb 2026 | 2,299,215 | -389,116 | $518.1M | -22.4% | 8.77% | EC |
| 3 | UNITEDHEALTH GROUP INC | UNH | Feb 2026 | 947,412 | +269,501 | $360.3M | +81.2% | 6.10% | EC |
| 4 | MERCK & COMPANY INC | MRK | Feb 2026 | 2,456,466 | +584,660 | $291.6M | +25.8% | 4.94% | EC |
| 5 | GILEAD SCIENCES INC | GILD | Feb 2026 | 1,841,333 | +104,911 | $247.5M | -4.3% | 4.19% | EC |
| 6 | ABBVIE INC | ABBV | Feb 2026 | 1,068,019 | -89,681 | $232.5M | -13.5% | 3.94% | EC |
| 7 | AMGEN INC | AMGN | Feb 2026 | 590,203 | +2,045 | $198.8M | -12.9% | 3.37% | EC |
| 8 | THERMO FISHER SCIENTIFIC INC | TMO | Feb 2026 | 362,337 | +77,051 | $178.5M | +20.0% | 3.02% | EC |
| 9 | VERTEX PHARMACEUTICALS INC | VRTX | Feb 2026 | 361,907 | +88,589 | $162.0M | +19.3% | 2.74% | EC |
| 10 | PFIZER INC | PFE | Feb 2026 | 5,899,018 | +4,714,396 | $154.4M | +371.5% | 2.61% | EC |
| 11 | EDWARDS LIFESCIENCES CORP | EW | Feb 2026 | 1,710,975 | — | $147.9M | +0.0% | 2.51% | EC |
| 12 | DANAHER CORP | DHR | Feb 2026 | 645,138 | -71,054 | $117.8M | -21.9% | 2.00% | EC |
| 13 | ABBOTT LABORATORIES | ABT | Feb 2026 | 1,361,894 | — | $116.6M | -26.4% | 1.97% | EC |
| 14 | INTUITIVE SURGICAL INC | ISRG | Feb 2026 | 271,432 | -47,619 | $115.3M | -28.3% | 1.95% | EC |
| 15 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Feb 2026 | 3,121,339 | -353,754 | $110.2M | -6.3% | 1.87% | EC |
| 16 | BOSTON SCIENTIFIC CORP | BSX | Feb 2026 | 1,945,032 | +660,670 | $94.0M | -4.8% | 1.59% | EC |
| 17 | ELEVANCE HEALTH INC | ELV | Feb 2026 | 234,947 | +146,342 | $92.4M | +225.8% | 1.56% | EC |
| 18 | ARGENX SE | ARGX | Feb 2026 | 88,995 | -32,345 | $74.4M | -20.1% | 1.26% | EC |
| 19 | BIOGEN INC | BIIB | Feb 2026 | 364,188 | — | $71.4M | +2.2% | 1.21% | EC |
| 20 | ASTRAZENECA PLC | AZN | Feb 2026 | 384,355 | +236,566 | $71.4M | +1.5% | 1.21% | EC |
| 21 | STRYKER CORP | SYK | Feb 2026 | 221,948 | -111,123 | $67.7M | -47.5% | 1.15% | EC |
| 22 | BLACKROCK FUNDS III | BISXX | Feb 2026 | 59,490,958 | +2,055,537 | $59.5M | +3.6% | 1.01% | STIV |
| 23 | REVOLUTION MEDICINES INC | RVMD | Feb 2026 | 361,340 | +58,345 | $56.9M | +84.1% | 0.96% | EC |
| 24 | HUMANA INC | HUM | Feb 2026 | 178,205 | +99,512 | $54.4M | +263.0% | 0.92% | EC |
| 25 | REGENERON PHARMACEUTICALS INC | REGN | Feb 2026 | 87,659 | — | $53.9M | -21.4% | 0.91% | EC |
| 26 | BRISTOL-MYERS SQUIBB COMPANY | BMY | Feb 2026 | 917,026 | -180,058 | $52.4M | -23.4% | 0.89% | EC |
| 27 | COGENT BIOSCIENCES INC | COGT | Feb 2026 | 1,406,858 | +586,439 | $49.2M | +54.3% | 0.83% | EC |
| 28 | DEXCOM INC | DXCM | Feb 2026 | 663,769 | — | $48.9M | +0.4% | 0.83% | EC |
| 29 | WATERS CORP | WAT | Feb 2026 | 124,449 | — | $47.7M | +20.1% | 0.81% | EC |
| 30 | CYTOKINETICS INC | CYTK | Feb 2026 | 575,188 | +390,411 | $44.2M | +284.0% | 0.75% | EC |
| 31 | PENUMBRA INC | PEN | Feb 2026 | 133,216 | — | $42.4M | -7.6% | 0.72% | EC |
| 32 | HCA HEALTHCARE INC | HCA | Feb 2026 | 111,627 | -14,078 | $42.3M | -36.5% | 0.72% | EC |
| 33 | INSMED INC | INSM | Feb 2026 | 392,149 | +90,796 | $41.9M | -6.8% | 0.71% | EC |
| 34 | CVS HEALTH CORP | CVS | Feb 2026 | 459,705 | +100,423 | $41.8M | +45.7% | 0.71% | EC |
| 35 | RHYTHM PHARMACEUTICALS INC | RYTM | Feb 2026 | 471,276 | -67,517 | $41.6M | -16.7% | 0.70% | EC |
| 36 | GALDERMA GROUP AG | GALD | Feb 2026 | 188,090 | NEW | $39.8M | — | 0.67% | EC |
| 37 | INCYTE CORP | INCY | Feb 2026 | 396,174 | — | $38.3M | -4.5% | 0.65% | EC |
| 38 | NOVARTIS AG | NVS | Feb 2026 | 251,660 | — | $37.8M | -10.9% | 0.64% | EC |
| 39 | PROTAGONIST THERAPEUTICS INC | PTGX | Feb 2026 | 370,408 | — | $36.9M | +8.1% | 0.62% | EC |
| 40 | AGILENT TECHNOLOGIES INC | A | Feb 2026 | 271,239 | — | $36.8M | +11.7% | 0.62% | EC |
| 41 | IDEXX LABORATORIES INC | IDXX | Feb 2026 | 65,102 | -9,519 | $36.7M | -25.1% | 0.62% | EC |
| 42 | NUVALENT INC | NUVL | Feb 2026 | 315,841 | — | $34.9M | +8.3% | 0.59% | EC |
| 43 | UNITED THERAPEUTICS CORP | UTHR | Feb 2026 | 55,689 | — | $31.0M | +10.5% | 0.53% | EC |
| 44 | ALNYLAM PHARMACEUTICALS INC | ALNY | Feb 2026 | 94,913 | -112,236 | $28.7M | -58.4% | 0.49% | EC |
| 45 | BRUKER CORP | BRKR | Feb 2026 | 471,949 | — | $27.8M | +46.8% | 0.47% | EC |
| 46 | MODERNA INC | MRNA | Feb 2026 | 560,799 | — | $26.5M | -11.9% | 0.45% | EC |
| 47 | IQVIA HOLDINGS INC | IQV | Feb 2026 | 141,190 | — | $25.7M | +1.9% | 0.44% | EC |
| 48 | ILLUMINA INC | ILMN | Feb 2026 | 145,933 | — | $23.8M | +21.2% | 0.40% | EC |
| 49 | MEDLINE INC | MDLN | Feb 2026 | 605,149 | -237,424 | $22.1M | -44.7% | 0.37% | EC |
| 50 | APOGEE THERAPEUTICS INC | APGE | Feb 2026 | 263,702 | +60,752 | $21.7M | +52.5% | 0.37% | EC |
| 51 | BLACKROCK LIQUIDITY FUNDS | TSTXX | Feb 2026 | 21,272,201 | -12,923,669 | $21.3M | -37.8% | 0.36% | STIV |
| 52 | MCKESSON CORP | MCK | Feb 2026 | 27,586 | -52,076 | $20.5M | -74.0% | 0.35% | EC |
| 53 | BIOMARIN PHARMACEUTICAL INC | BMRN | Feb 2026 | 322,635 | — | $18.5M | -7.2% | 0.31% | EC |
| 54 | NEUROCRINE BIOSCIENCES INC | NBIX | Feb 2026 | 113,005 | +34,284 | $17.9M | +71.8% | 0.30% | EC |
| 55 | DIANTHUS THERAPEUTICS INC | DNTH | Feb 2026 | 186,482 | +78,449 | $17.3M | +190.9% | 0.29% | EC |
| 56 | ROIVANT SCIENCES LTD | ROIV | Feb 2026 | 563,855 | NEW | $16.9M | — | 0.29% | EC |
| 57 | QUEST DIAGNOSTICS INC | DGX | Feb 2026 | 85,193 | — | $16.6M | -8.0% | 0.28% | EC |
| 58 | LB PHARMACEUTICALS INC | LBRX | Feb 2026 | 567,627 | — | $15.9M | +16.5% | 0.27% | EC |
| 59 | UCB SA | UCB | Feb 2026 | 53,577 | NEW | $15.7M | — | 0.27% | EC |
| 60 | ORUKA THERAPEUTICS INC | ORKA | Feb 2026 | 264,813 | +79,798 | $15.5M | +143.5% | 0.26% | EC |
| 61 | STOKE THERAPEUTICS INC | STOK | Feb 2026 | 473,152 | — | $14.6M | -15.1% | 0.25% | EC |
| 62 | ARCUS BIOSCIENCES INC | RCUS | Feb 2026 | 572,430 | +116,888 | $14.5M | +56.3% | 0.25% | EC |
| 63 | MADRIGAL PHARMACEUTICALS INC | MDGL | May 2026 | 27,588 | NEW | $13.7M | — | 0.23% | EC |
| 64 | IONIS PHARMACEUTICALS INC | IONS | Feb 2026 | 170,008 | — | $13.0M | -5.7% | 0.22% | EC |
| 65 | CENCORA INC | COR | Feb 2026 | 46,310 | -219,550 | $12.5M | -87.4% | 0.21% | EC |
| 66 | EXELIXIS INC | EXEL | Feb 2026 | 231,652 | — | $11.7M | +14.6% | 0.20% | EC |
| 67 | ELANCO ANIMAL HEALTH INC | ELAN | Feb 2026 | 483,249 | — | $11.5M | -9.7% | 0.20% | EC |
| 68 | DAIICHI SANKYO COMPANY LTD | 4568 | Feb 2026 | 673,800 | NEW | $11.3M | — | 0.19% | EC |
| 69 | SCHOLAR ROCK HOLDING CORP | SRRK | Feb 2026 | 226,209 | — | $11.2M | +11.4% | 0.19% | EC |
| 70 | ADARX PHARMACEUTICALS INC | 000000000 | Feb 2026 | 769,230 | NEW | $10.9M | — | 0.18% | EC |
| 71 | KAILERA THERAPEUTICS INC | KLRA | May 2026 | 464,174 | NEW | $10.6M | — | 0.18% | EC |
| 72 | WEST PHARMACEUTICAL SERVICES INC | WST | Feb 2026 | 32,517 | -27,912 | $10.5M | -31.7% | 0.18% | EC |
| 73 | MBX BIOSCIENCES INC | MBX | Feb 2026 | 333,350 | — | $10.5M | -3.3% | 0.18% | EC |
| 74 | NATERA INC | NTRA | Feb 2026 | 46,190 | -84,089 | $10.3M | -61.9% | 0.17% | EC |
| 75 | CHARLES RIVER LABORATORIES INTERNATIONAL INC | CRL | Feb 2026 | 56,177 | — | $10.2M | +1.2% | 0.17% | EC |
| 76 | BIO-TECHNE CORP | TECH | Feb 2026 | 193,925 | — | $10.0M | -12.4% | 0.17% | EC |
| 77 | KAILERA THERAPEUTICS INC | 000000000 | Feb 2026 | 428,000 | NEW | $9.8M | — | 0.17% | EC |
| 78 | NOVOCURE LTD | NVCR | Feb 2026 | 574,295 | NEW | $9.8M | — | 0.17% | EC |
| 79 | INTELLIA THERAPEUTICS INC | NTLA | Feb 2026 | 664,846 | +146,454 | $9.4M | +31.0% | 0.16% | EC |
| 80 | ERASCA INC | ERAS | Feb 2026 | 709,864 | — | $9.1M | -6.0% | 0.15% | EC |
| 81 | VIRIDIAN THERAPEUTICS INC | VRDN | Feb 2026 | 516,095 | — | $9.1M | -40.0% | 0.15% | EC |
| 82 | GLAUKOS CORP | GKOS | Feb 2026 | 87,150 | — | $9.0M | -14.2% | 0.15% | EC |
| 83 | AXSOME THERAPEUTICS INC | AXSM | May 2026 | 38,178 | NEW | $9.0M | — | 0.15% | EC |
| 84 | BRIGHT MINDS BIOSCIENCES INC | DRUG | Feb 2026 | 95,655 | — | $8.4M | +5.1% | 0.14% | EC |
| 85 | AGIOS PHARMACEUTICALS INC | AGIO | Feb 2026 | 271,615 | -73,261 | $8.0M | -23.4% | 0.14% | EC |
| 86 | EIKON THERAPEUTICS INC | EIKN | Feb 2026 | 722,389 | — | $7.8M | -21.3% | 0.13% | EC |
| 87 | VAXCYTE INC | PCVX | Feb 2026 | 147,352 | +59,812 | $7.6M | +40.1% | 0.13% | EC |
| 88 | LARONDE INC | 000000000 | Feb 2026 | 386,520 | NEW | $7.5M | — | 0.13% | EC |
| 89 | METTLER-TOLEDO INTERNATIONAL INC | MTD | Feb 2026 | 6,058 | +1,464 | $7.2M | +13.9% | 0.12% | EC |
| 90 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 1,233,856 | NEW | $7.0M | — | 0.12% | EC |
| 91 | Angitia Biopharmaceuticals Limited | 000000000 | Feb 2026 | 658,956 | NEW | $6.5M | — | 0.11% | EC |
| 92 | ENANTA PHARMACEUTICALS INC | ENTA | Feb 2026 | 492,001 | — | $6.5M | -8.0% | 0.11% | EC |
| 93 | ALUMIS INC | ALMS | Feb 2026 | 293,662 | — | $6.3M | -27.2% | 0.11% | EC |
| 94 | IMMUNOME INC | IMNM | Feb 2026 | 288,792 | — | $6.3M | -0.1% | 0.11% | EC |
| 95 | MONTE ROSA THERAPEUTICS INC | GLUE | Feb 2026 | 318,162 | — | $6.3M | +11.0% | 0.11% | EC |
| 96 | GENESIS THERAPEUTICS INC | 000000000 | Feb 2026 | 823,870 | NEW | $6.1M | — | 0.10% | EC |
| 97 | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BBOT | Feb 2026 | 673,766 | — | $6.0M | -10.6% | 0.10% | EC |
| 98 | PALVELLA THERAPEUTICS INC | PVLA | May 2026 | 50,716 | NEW | $6.0M | — | 0.10% | EC |
| 99 | RADNET INC | RDNT | Feb 2026 | 108,100 | — | $6.0M | -20.5% | 0.10% | EC |
| 100 | BRIDGEBIO PHARMA INC | BBIO | Feb 2026 | 86,968 | -117,906 | $5.8M | -57.7% | 0.10% | EC |
| 101 | KALVISTA PHARMACEUTICALS INC | KALV | Feb 2026 | 212,587 | — | $5.7M | +65.0% | 0.10% | EC |
| 102 | BEAM THERAPEUTICS INC | BEAM | Feb 2026 | 168,010 | — | $5.5M | +15.7% | 0.09% | EC |
| 103 | AKTIS ONCOLOGY INC | AKTS | Feb 2026 | 266,503 | — | $5.5M | +3.0% | 0.09% | EC |
| 104 | IMMUNOCORE HOLDINGS PLC | IMCR | Feb 2026 | 188,691 | — | $5.5M | -10.6% | 0.09% | EC |
| 105 | DYNE THERAPEUTICS INC | DYN | Feb 2026 | 278,934 | — | $5.4M | +23.8% | 0.09% | EC |
| 106 | DENALI THERAPEUTICS INC | DNLI | Feb 2026 | 251,859 | -77,320 | $5.3M | -24.0% | 0.09% | EC |
| 107 | MAZE THERAPEUTICS INC | MAZE | Feb 2026 | 184,453 | — | $4.9M | -42.0% | 0.08% | EC |
| 108 | SUMMIT THERAPEUTICS INC | SMMT | Feb 2026 | 276,987 | -647,161 | $4.9M | -68.3% | 0.08% | EC |
| 109 | RELAY THERAPEUTICS INC | RLAY | May 2026 | 342,957 | NEW | $4.8M | — | 0.08% | EC |
| 110 | AVALO THERAPEUTICS INC | AVTX | May 2026 | 299,585 | NEW | $4.8M | — | 0.08% | EC |
| 111 | KODIAK SCIENCES INC | KOD | Feb 2026 | 128,647 | -60,122 | $4.7M | -6.6% | 0.08% | EC |
| 112 | KYMERA THERAPEUTICS INC | KYMR | Feb 2026 | 54,173 | — | $4.4M | -10.9% | 0.07% | EC |
| 113 | ALCON AG | ALC | Feb 2026 | 65,553 | NEW | $4.3M | — | 0.07% | EC |
| 114 | SAGIMET BIOSCIENCES INC | SGMT | May 2026 | 585,181 | NEW | $4.3M | — | 0.07% | EC |
| 115 | BIONTECH SE | BNTX | Feb 2026 | 41,921 | — | $4.0M | -13.0% | 0.07% | EC |
| 116 | INSITRO INC | 000000000 | Feb 2026 | 592,636 | NEW | $4.0M | — | 0.07% | EC |
| 117 | BIOHAVEN LTD | BHVN | Feb 2026 | 348,832 | NEW | $3.8M | — | 0.07% | EC |
| 118 | ZEALAND PHARMA A/S | ZEAL | Feb 2026 | 74,091 | NEW | $3.8M | — | 0.06% | EC |
| 119 | PTC THERAPEUTICS INC | PTCT | Feb 2026 | 48,954 | -34,016 | $3.6M | -36.1% | 0.06% | EC |
| 120 | BICARA THERAPEUTICS INC | BCAX | May 2026 | 160,104 | NEW | $3.5M | — | 0.06% | EC |
| 121 | QUANTA DIALYSIS TECHNOLOGIES LTD | 000000000 | Feb 2026 | 80,024,425 | NEW | $3.4M | — | 0.06% | EC |
| 122 | ULTRAGENYX PHARMACEUTICAL INC | RARE | May 2026 | 130,855 | NEW | $3.1M | — | 0.05% | EC |
| 123 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | May 2026 | 161,391 | NEW | $3.1M | — | 0.05% | EC |
| 124 | UPSTREAM BIO INC | UPB | Feb 2026 | 341,675 | — | $2.9M | +8.9% | 0.05% | EC |
| 125 | ALLOGENE THERAPEUTICS INC | ALLO | Feb 2026 | 1,208,862 | — | $2.6M | -21.9% | 0.04% | EC |
| 126 | EYEPOINT INC | EYPT | Feb 2026 | 186,478 | — | $2.5M | -22.7% | 0.04% | EC |
| 127 | OCULAR THERAPEUTIX INC | OCUL | Feb 2026 | 258,781 | — | $2.3M | +0.8% | 0.04% | EC |
| 128 | WAVE LIFE SCIENCES LTD | WVE | Feb 2026 | 345,882 | NEW | $2.3M | — | 0.04% | EC |
| 129 | DEFINIUM THERAPEUTICS INC | DFTX | May 2026 | 81,265 | NEW | $2.0M | — | 0.03% | EC |
| 130 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 339,469 | NEW | $1.9M | — | 0.03% | EC |
| 131 | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | 000000000 | Feb 2026 | 209,287 | NEW | $1.9M | — | 0.03% | EC |
| 132 | VOR BIOPHARMA INC | VOR | Feb 2026 | 115,078 | — | $1.7M | -3.0% | 0.03% | EC |
| 133 | REGENXBIO INC | RGNX | Feb 2026 | 214,663 | — | $1.5M | -22.5% | 0.03% | EC |
| 134 | MAPLIGHT THERAPEUTICS INC | MPLT | May 2026 | 50,257 | NEW | $1.5M | — | 0.02% | EC |
| 135 | CORVUS PHARMACEUTICALS INC | CRVS | Feb 2026 | 110,424 | — | $1.4M | -32.0% | 0.02% | EC |
| 136 | 4D MOLECULAR THERAPEUTICS INC | FDMT | Feb 2026 | 126,274 | — | $1.3M | +2.6% | 0.02% | EC |
| 137 | SYNDAX PHARMACEUTICALS INC | SNDX | May 2026 | 58,560 | NEW | $1.1M | — | 0.02% | EC |
| 138 | ANNEXON INC | ANNX | May 2026 | 188,611 | NEW | $1.0M | — | 0.02% | EC |
| 139 | NYXOAH SA | NYXH | Feb 2026 | 337,359 | NEW | $1.0M | — | 0.02% | EC |
| 140 | GOLDFINCH BIO INC | 000000000 | Feb 2026 | 3,115,353 | NEW | $935K | — | 0.02% | EC |
| 141 | ORCHESTRA BIOMED HOLDINGS INC | OBIO | Feb 2026 | 206,130 | — | $806K | -10.7% | 0.01% | EC |
| 142 | EXO IMAGING INC | 000000000 | Feb 2026 | 890,877 | NEW | $659K | — | 0.01% | EP |
| 143 | KARTOS THERAPEUTICS INC | 000000000 | Feb 2026 | 614,446 | NEW | $636K | — | 0.01% | EC |
| 144 | CELLARITY INC | 000000000 | Feb 2026 | 858,333 | NEW | $498K | — | 0.01% | EC |
| 145 | AFFINIVAX INC | 000000000 | Feb 2026 | 122,824 | NEW | $450K | — | 0.01% | EC |
| 146 | ABIOMED INC | 2223637D | Feb 2026 | 243,643 | — | $368K | -34.9% | 0.01% | — |
| 147 | BLUEPRINT MEDICINES CORP | BPMC | Feb 2026 | 204,909 | — | $203K | -1.0% | 0.00% | EC |
| 148 | MIRATI THERAPEUTICS INC | MRTX | Feb 2026 | 228,510 | — | $181K | +0.0% | 0.00% | EC |
| 149 | GOSSAMER BIO INC | GOSS | Feb 2026 | 365,199 | — | $84K | -45.7% | 0.00% | EC |
| 150 | EXO IMAGING INC | 000000000 | Feb 2026 | 19,083 | NEW | $7K | — | 0.00% | EC |
| 151 | ARCELLX INC | ACLX | Feb 2026 | 92,964 | — | $7K | -99.9% | 0.00% | EC |
| 152 | SWIFT HEALTH SYSTEMS INC | 000000000 | Feb 2026 | 1,700 | NEW | $4K | — | 0.00% | EC |
| 153 | HOLOGIC INC | HOLX | May 2026 | 138,368 | NEW | $1K | — | 0.00% | EC |
| 154 | FREQUENCY THERAPEUTICS CVR | 000000000 | Feb 2026 | 428,010 | NEW | $4 | — | 0.00% | EC |
| 155 | GOLDFINCH EQUITY WARRANTS | 000000000 | Feb 2026 | 403,447 | NEW | $4 | — | 0.00% | DE |
| ✕ | Exact Sciences Corporation | 30063P105 | — | 548,069 | SOLD | $56.7M | — | — | — |
| ✕ | Guardant Health Inc | 40131M109 | — | 336,665 | SOLD | $31.6M | — | — | — |
| ✕ | The Cooper Companies, Inc. | 216648501 | — | 293,135 | SOLD | $24.5M | — | — | — |
| ✕ | Centene Corp. | 15135B101 | — | 545,618 | SOLD | $24.5M | — | — | — |
| ✕ | GE Healthcare Technologies Inc. | 36266G107 | — | 226,856 | SOLD | $19.1M | — | — | — |
| ✕ | Veeva Systems Inc | 922475108 | — | 99,401 | SOLD | $18.1M | — | — | — |
| ✕ | Repligen Corporation | 759916109 | — | 136,584 | SOLD | $17.6M | — | — | — |
| ✕ | Terns Pharmaceuticals Inc. | 880881107 | — | 367,842 | SOLD | $15.5M | — | — | — |
| ✕ | Viking Therapeutics Inc. | 92686J106 | — | 425,324 | SOLD | $14.4M | — | — | — |
| ✕ | Hologic Inc | 436440101 | — | 138,368 | SOLD | $10.4M | — | — | — |
| ✕ | Ventyx Biosciences Inc. | 92332V107 | — | 590,649 | SOLD | $8.3M | — | — | — |
| ✕ | Edgewise Therapeutics Inc. | 28036F105 | — | 256,164 | SOLD | $7.8M | — | — | — |
| ✕ | Avidity Biosciences Inc. | 05370A108 | — | 99,483 | SOLD | $7.2M | — | — | — |
| ✕ | Olema Pharmaceuticals Inc. | 68062P106 | — | 253,931 | SOLD | $6.1M | — | — | — |
| ✕ | Disc Medicine Inc | 254604101 | — | 86,558 | SOLD | $5.8M | — | — | — |
| ✕ | CG Oncology Inc. | 156944100 | — | 59,514 | SOLD | $3.5M | — | — | — |
| ✕ | Voyager Therapeutics Incorporation | 92915B106 | — | 371,161 | SOLD | $1.5M | — | — | — |
| ✕ | Autolus Therapeutics PLC | 05280R100 | — | 728,967 | SOLD | $1.2M | — | — | — |
| ✕ | TScan Therapeutics Inc | 89854M101 | — | 556,653 | SOLD | $0.6M | — | — | — |
| ✕ | Atrium Therapeutics Inc. | 04965N104 | — | 9,948 | SOLD | $0.1M | — | — | — |